General Information
Application | Inhibitor |
---|
Description | Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively. |
---|
Cas NO. | 231277-92-2 |
---|
Purity | ≥99% |
---|---|
Molecular Weight | 581.06 |
Formula | C29H26ClFN4O4S |
Solubility |
DMSO : 100 mg/mL Ethanol : Insoluble Water : Insoluble |
---|
Target / IC50 |
ErbB2 : 9.2 nM ErbB4 : 367 nM EGFR : 10.8 nM |
---|
Storage |
Powder : -20°C for 3 years |
---|
Alias | N/A |
---|
|
1 mg |
5 mg |
10 mg |
|
1 mM |
1.7210 mL | 8.6050 mL | 17.2099 mL | |
5 mM | 0.3442 mL | 1.7210 mL | 3.4420 mL | |
10 mM | 0.1721 mL | 0.8605 mL | 1.7210 mL |